In recent trading, shares of Becton, Dickinson & Co (Symbol: BDX) have crossed above the average analyst 12-month target price of $200.40, changing hands for $200.43/share. When a stock reaches the ...

Becton, Dickinson and Company (NYSE:BDX) is included among the 15 Best Stocks to Buy for the Long Term. On December 2, Morgan Stanley analyst Patrick Wood lifted the firm’s price target on Becton, ...

Becton, Dickinson and Company (BDX) develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products. Valued at $55.4 billion by market cap, the company ...

This season, the Los Angeles Chargers have dealt with a myriad number of issues with their offensive line. The latest however, doesn’t just stem from an injury. Becton is just one year removed from ...

Los Angeles Chargers offensive lineman Mekhi Becton isn’t too happy with the team, it seems. Becton, the team’s prized free-agent signing last offseason, has battled an assortment of injuries and at ...

With season-ending injuries to Rashawn Slater and Joe Alt and a (so far) failed trade for Trevor Penning, the Los Angeles Chargers' offensive line this season has been a complete mess. Thanks got ...

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It ...